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Abstract
The adoption of electronic sourcing promises to bring in free-market competition so as to achieve
significant cost reduction. However, this promise has not been realized in the healthcare industry
in China after years of e-sourcing adoption. Instead, adoption of e-sourcing has steadily
increased the cost of pharmaceutical products that hospitals charged to patients. Our study
indicates that this paradox was caused neither by the lack of market control mechanism nor the
resistance to market process reengineering. Taking a contextualist perspective, this paper
examines three embedded levels of context so as to appreciate the internalization problem
underlying e-sourcing adoption in Chinese healthcare sector. The findings indicate that
technology is unable to be internalized effectively if the alignment of context at three levels –
societal (society), industrial (industry) and organizational (organization) – is not given due
consideration during adoption and implementation.
Keywords: Case study, Electronic sourcing, Contextualist, Healthcare

1. Introduction
Centuries ago, Scottish economist Adam Smith advocated the idea of a free-market system. In
his famous book, Wealth of Nations, Smith explained, a participant in the free-market “intends
only his own gain, and he is in this, as in many other cases, led by an invisible hand to promote
an end which was not part of his intention” (Copley and Sutherland, 1995). The greatest virtue of
a free-market was that productive outcome arises as the unintended consequence of rational
self-interest. His idea has been realized two centuries later, through the use of e-sourcing
(electronic sourcing). By aggregating purchase volume, e-sourcing demonstrates its economic
value through reverse auction enabled by information systems (Kaplan and Sawhney, 2000).
In China, a longstanding problem facing the government is that increasingly, citizens found the
prices of medicine become increasingly unaffordable. In the search for a solution to this problem,
the Chinese government was attracted by the free-market concept inherent in e-sourcing.
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Consequently, e-sourcing was adopted for the healthcare industry in a number of cities, with the
hope to reduce the medicine expenses. In one of the cities, hereafter called South City1, the
implementation of e-sourcing system was a great success; by the end of 2003, 94% of hospitals
in South city had accepted the e-sourcing system provided by the government to procure
pharmaceutical goods and other medical supplies. However, to the adopters’ bewilderment, the
cost of medicine in general had not decreased but actually increased substantially. The adoption
of e-sourcing, which was meant to alleviate the overloaded social security system, paradoxically
became its burden. In this research, we address this issue by examining technology
internalization using a contextualist perspective (Kostova, 1999). By internalization, we mean
how well adopters attach positive symbolic value (e.g. in terms of commitment, satisfaction and
ownership of e-sourcing) to, and achieve effective exploitation of, e-sourcing. We ask: How
could a successful implemented system fail to be internalized by the recipient organization and
result in counterproductive outcomes, in a given context?
The objective of this paper is to explain the issue of internalization within technology adoption
and to elaborate how the contextualist perspective can be employed to provide a viable
alternative understanding of the outcome of e-sourcing adoption. We anchor our study in a
field-based case study which analyzes e-sourcing adoption in China’s healthcare sector.
Theoretical and practical implications are discussed.

2. Theoretical Basis: A Contextualist Perspective
The current literature mainly examines e-sourcing adoption failure in terms of the lack of market
control mechanisms and resistance to market process reengineering (e.g. Lee and Clark, 1997).
For example, Aberdeen Group (2001) suggested e-sourcing implementation may be inhibited by
insufficient technical functions, a lack of top management support, and resistance from the
suppliers who participate in the online negotiation. Kambil and van Heck (1998) analyzed Dutch
Flower auction and found that the lack of sound market control mechanism (such as fair
information exchange and efficient transaction) affected usage and acceptance of the e-auction
system. They observed that e-market system adoption altered the relative costs and benefits to
actors, or the power of actors, leading to renegotiation of consensus. Unsuccessful renegotiation
would inevitably lead to failed adoption. Thus, implementers should devise incentives and
processes to facilitate consensus building. Lee and Clark (1997) examined four e-sourcing cases,
in which two cases were successful and another two were failed. They suggested that the major
inhibitors to e-sourcing failure include the fears toward transaction risks, the resistance to
efficient market process reengineering, and the powerlessness to enforce changes in the market
participants’ sourcing methods.
Nevertheless, these analyses only explain how to ensure effective “implementation” of
e-sourcing. They do not examine whether e-sourcing could be “internalized” by the recipient
firm. Without attending to the internalization issue, we are unable to understand whether a
successful e-sourcing adoption would eventually lead to anticipated benefits. Further, previous
studies seem to focus mainly on system functions, control mechanisms, and organizational

1

All the names of cities, organizations and institutions in this paper are pseudonyms as requested.
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inertia. They pay scant attention to the “context” in which e-sourcing is adopted and the recipient
firm is situated. This insensitivity to context may result in adopting an effective system in a
completely inappropriate context.
Therefore, we propose to analyze this issue though a contextualist perspective (cf. Kostova, 1999;
Pettigrew, 1990, 1997). This perspective suggests that technology does not exist in a vacuum.
When technology is adopted, the inscribed practices are also transferred to the recipient
organization. Those practices may fit in some recipient organizations’ context but they may also
become a disturbance in the situated context. The alignment of technology and context thus is an
indicator of how likely a technology may be internalized by the recipient’s organization. For
example, Kumar et al. (1998) found that, in Prato’s (Italy) textile industry, the online market was
considered disruptive to the Prato merchants’ socio-cultural context where trustful relationships
have been built through a close-knitted network. Similarly, Avgerou (2001) analyzed e-market
adoption failure in the furniture industry of Cyprus in 1990s. The Cyprus government set out
with the idea to adopt online market to facilitate flexible manufacturing. Avgerou (2001) found
that the failure was not about technology or implementation method. For the
small-and-medium-sized enterprises in Cyprus, the adoption of online market and flexible
manufacturing systems would result in highly specialized business organizations. This would
mean bringing in professional managers and re-structuring family-owned firms. It was
considered inapplicable to the adopters because such as a practice did not align with the
socio-cultural context which has established in Cyprus over generations.
Technology is used by people who are situated in context at multiple levels, as Pettigrew (1990:
270) suggested. Kostova (1999: 311) extended this idea and examined how knowledge transfer is
affected by three embedded contexts and resulted in two modes of outcome – i.e. implementation
and internalization. The first mode of outcome refers to how effectively the recipient
“implements” the practices (including the formal rules and systems), while the second mode is
concerned with how well the practice is “internalized” and assimilated into the recipient’s
context (e.g. commitment, satisfaction and ownership of the practice, leading to an effective
exploitation of the transferred practice). According to Kostova (1999), the transfer of strategic
practices (e.g. Total Quality Management or six-sigma discipline) could be examined through
three embedded levels of context, with reference to social, organizational and relational context.
Social context is related to regulatory, normative and cognitive characteristics of institutional
environment. Organizational context refers to the environment which may be conducive or
inhibiting to a firm’s ability to learn from previous mistakes and initiate changes, as well as to
whether the transferred practice is compatible with the existing practices. Relational context
refers to the recipient’s commitment, perceived identity and trust to the source. In short, these
contexts contain a value system that influences people’s actions and results in two major
outcomes of technology adoption – i.e. how effective the technology is implemented and how
well the technology is internalized. Taking technology into consideration, DeSanctis and Poole
(1994) further suggested that a technology contains both structural (including specific rules,
resources and capabilities) as well as the contextual features (e.g. the goals, values and norms
underlying a given set of structural features). Successful technology assimilation thus requires an
alignment between technological structures and organizational context (Majchrzak et al. 2000).
Extending Kostova’s (1999) contextualist analysis, we investigate how well an e-market system
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is aligned within three levels of context – society (societal), industry (industrial) and organization
(organizational), as shown in Figure 1. (Note: Kostova’s social context can be more accurately
described as “societal context”; the analysis of relational context is not applicable to our study, as
we do not have a problem of headquarters-subsidiaries conflict; an analysis of industrial
context – surrounding the issue enacted from pharmaceutical companies – is more appropriate in
our study.) At the societal context, technology adoption needs to align with the institutional
characteristics of a particular society. For Chinese healthcare sector, the institutional
characteristics include its regulations of medical treatment processes, norms and cognitions of
people towards the whole industry. At the industrial level, technology adoption needs to align
with industrial dynamics – that is, the features, norms and values that are embedded in products,
services and common practices. These industrial dynamics for the healthcare sourcing practices
involve categories, quality and judging criteria of pharmaceuticals and other materials. At the
organizational level, technology adoption needs to align with an organization’s attitude towards
learning and change. In the healthcare industry, this relates to culture and attitudes of key players
in the supply chain, including manufacturers, suppliers and hospitals. In the next section, we will
explain how the contextualist analysis is employed to examine the difficulty of internalizing
e-sourcing in Chinese healthcare sector.
Figure 1: A Contextualist Analysis of Technology Internalization (adapted from Kostova, 1999)
Societal context
Regulated environment
Cognitive inertia

Industrial context
Product specification
(containing tacit knowledge )

The alignment
with technology

Effectiveness of
internalization

Organizational context
Organizational culture
Attitude toward innovation

3. Research method
Case study method is used in this research. We follow Eisenhardt’s (1989) eight-step framework
to conduct the case study, which include defining the research question(s), selecting case(s),
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crafting instruments and protocols, collecting data, analyzing data, shaping theoretical logic and
perspective, comparing with past literature and theoretical saturation. For research question, we
aimed to identify contextual misalignment of e-sourcing and Chinese healthcare industry, and to
explain its internalization problem. For case selection, we chose South City because it has the
highest adoption rate and is often known as a model city in implementing e-sourcing in the
healthcare industry. Five hospitals were selected for in-depth investigation, including two large,
two medium and one small size hospitals. 2 We conducted fieldwork in South City from
September to November in 2004. We interviewed five purchasing staff in each hospital as well
as members of online auction appraisal committee (comprising of twelve medical doctors).
Moreover, we interviewed officers from the Ministry of Health in South City, an institution
which launched and supervised the e-sourcing project for pharmaceutical purchasing. To enrich
our understanding of the pharmaceutical industry, we also visited a major multinational company
(which has established its presence in China for more than ten years) and interviewed four
strategic purchasing managers, in addition to four CEOs from domestic pharmaceutical
companies. We also analyze archival documents from 2000 to 2003 in order to enrich our
understanding of this industry.
For data collection, we collected and analyzed field data according to the contextualist lens at
societal, industrial, and organizational level. We crafted our instruments by asking questions
such as: How did regulations and policies in contemporary China affect hospital purchasing
(societal level)? How did the use of e-sourcing method affect sourcing practices situated in
healthcare sector (industrial level)? How did e-sourcing confirm or disturb hospital’s purchasing
practices (organizational level)? On this basis, we analyzed the failure of e-sourcing
internalization with reference to how well the sourcing practices embedded in e-sourcing are
aligned with the practices situated at the three different levels.

4. Research Findings: The Misalignment of Context in e-Sourcing Internalization
As a result of open market policy in China, medical expenses have risen significantly in the past
few years. This led to an increase in medical expenditure in contemporary China. A major
problem commonly perceived in China’s healthcare sector was the unreasonable drug prices.
Most Chinese citizens believed that such high prices reflect the lack of transparency in the
healthcare sector. With the advent of electronic commerce at the end of last century, the Chinese
government realized that e-sourcing may help to reduce prices by facilitating centralized
pharmaceutical purchasing. Therefore, in 2000, through the advocacy of the National Economy
Development Committee and the Ministry of Health, many cities began to form hospital
consortiums and adopted e-sourcing in the hope of reducing the cost of medicine expenses.
South City was among the first in China to adopt e-sourcing for the healthcare sector. The
council committee attempted to employ competitive bidding to purchase pharmaceutical
products. The sourcing team needed to coordinate with three stakeholders: supervisors
committee, appraisal committee and service provider. The supervisors committee consisted of
governmental agencies (e.g. Ministry of Health, Pharmaceutical Administration, Price

2

In China, the size of hospitals is defined by the number of beds. A hospital with more than 1,000 beds is
defined as large and the one with less than 300 is known as small.
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Administration, etc.) that define regulations and processes related to e-sourcing practice; the
appraisal committee was constituted of medical doctors from twelve selected hospitals of the city,
who were in charge of assessing suppliers and assigning the bids; the service provider was in
charge of the functioning and maintenance of the e-sourcing system. In 2000, the South City’s
municipal government issued an administrative request and mandated large- and medium-sized
hospitals to adopt e-sourcing for managing their spending. The implementation of e-sourcing
was a great success; by the end of 2003, about 94% of pharmaceuticals of the city were
purchased through e-sourcing.
The online negotiation was conducted according to the following steps. First, hospitals would
report their purchase needs of pharmaceutical products. The sourcing team would then aggregate
the demands according to different categories, quantity and quality, across more than 10,000
categories of pharmaceutical products. Next, suppliers were asked to provide their quality
certifications, production capabilities, price per unit, and related information for RFQ (request
for quotation). The sourcing team then assessed the suppliers’ specification, conducted reverse
auction, and awarded the contract.
The municipal government of South City was relatively satisfied with the e-sourcing
implementation in terms of enhanced efficiency and transparency of procurement. However, the
average price of pharmaceutical products actually arose and the total healthcare expenses in that
city were also increased, as a doctor explained:
Although official statistics reported that drug prices had decreased substantially,
the prices of some drugs have actually increased. For example, the price of
Vitamin E Nicotinicate Capsules went up 1.8 times to RMB 19.80 after the
bidding. And in many cases, for the same drug, the price from hospitals which
had used e-sourcing is usually much higher than that from drugstores which had
not adopted e-sourcing. Another example: a kind of injection medicine is sold in
drugstores at RMB 18.6, but in hospitals at RMB 112.7. A diabetes medicine is
sold at RMB 9 in drugstores, but when it comes to hospitals, the price goes up to
more than RMB 40. Examples of this kind are plenty.
Consequently, neither hospitals nor patients benefited from the e-sourcing method. The sourcing
team was puzzled with the outcome and wondered what control mechanism could be brought in
to facilitate e-sourcing so that healthcare cost could be reduced. The following subsections
investigate misalignment of e-sourcing in three embedded contexts and explore why e-sourcing
was not effectively internalized by South City.
Misalignment in the societal context: The e-sourcing system assumes a “free market” principle,
which suggests open market participation, information transparency, and rational transaction. In
a “free market” context, market participants are able to make purchasing or producing decision at
their own will and on an economy or efficiency basis.
Nevertheless, such a “free market” context does not exist in Chinese healthcare industry.
Although the Chinese government has tried to build hospitals into independent financial units, its
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economic activities are highly regulated in terms of the incorporation of hospitals, the clinical
charge for medical treatment, the selection of suppliers, and the choice of medicine. The profit
structure of Chinese hospitals illustrated the characteristics of this regulated market. In China,
there are three components of hospital revenue. The first is consultation fee, including the
expense of diagnosis, medical checkup and hospitalization. This fee is maintained at a relatively
low level as a result of government intervention. A standard baseline of hospital treatment fee is
set by the central government. As most citizens are used to the clinical treatment fee, it is very
difficult for hospitals to increase this fee (which was also a “politically-correct” concern). The
second component is fee subsidized by the affiliated institutions; and the third component is from
the sale of pharmaceutical products. In China, institutions such as the railway or post-office have
their affiliated hospitals. However, Chinese government has begun to reduce the second
component, which significantly shrinks the income of hospitals.
The central government required hospitals to become economically independent as a result of
market economy policy. It was the first time in the modern Chinese history that hospitals must be
self-sustainable financially. However, since it was not possible (politically) to increase the
medical treatment fee, the revenue derived from pharmaceutical products became a main source
of income for most hospitals. A hospital sourcing staff remarked:
It’s not in the benefit of hospitals to drive down the OTC (over-the-counter)
drug prices. Hospitals are not allowed to decide selling prices. We sell at fixed
rate, which is regulated. Therefore, we prefer the purchasing price to be high
because that is the only way we can boost up profits. It also causes less public
stir-up as most patients will accept the price as given.
The regulation in the healthcare industry in China also constrained the selection of suppliers. For
example, strict supplier certification policy stipulated that suppliers’ R&D must be supervised,
monitored and the pricing structure set by the Pharmaceutical Administration and the Price
Administration. In this case, the “invisible hand” was no longer in the hand of the market, but in
the hand of the local government. This ran counter to the “free-market” assumption embedded in
e-sourcing. One manager form a large pharmaceutical company said:
Largely it’s the “public relationship” work to help us sell products. Without
working on guanxi (relationship), pharmaceutical companies can hardly obtain
approval from local agencies. As well, you also cannot sell your products at a
profitable price range. Pharmaceutical companies need profits; hospitals need
profits; and so do the local government. The local income tax depends heavily
on pharmaceutical companies. Therefore, if our pharmaceutical products are
approved, even at a higher price, everyone will be happy.
There was also a cognitive barrier to exploit e-sourcing fully. In its socialist policy, Chinese
government had subsidized public medical expenses for at least forty years. Consequently, the
perception that medical expenses “should” be paid by the government could not be changed
easily. Since certain categories of pharmaceutical products are covered by the social security
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(sponsored by local government fund), it encouraged people to buy pharmaceutical products
from hospitals rather than from drugstores. (Note: citizens would not get refund if they brought
medicine from drugstores.) Understandably, hospitals were willing to sell pharmaceutical
products at higher prices so as to be self-sustainable. Both the hospital administrator and patients
found this to be a good solution to their financial dilemma. Consequently, although the
e-sourcing practice was adopted as a result of government push, the misalignment with China’s
societal contextual hampered its internalization. The “free-market” assumption of e-sourcing was
in direct conflict with the highly regulated institutional environment in China.
Misalignment in the industrial context: E-sourcing assumes a rational model of transaction,
which requires unambiguous purchase specification to serve as a basis for rational decisions.
With the same benchmark criterion, buyer can make purchase decision by looking into a set of
factors such price, product quality, delivery time, and service warranty. With the objective
measures, adopters can also apply the transformational-bidding principle by assigning
discrimination in certain criteria. For example, although a supplier may offer lower prices, its
delivery charge and time-to-market may be higher. As a result, the supplier may still lose the bid.
However, in the healthcare industry, the specification of pharmaceutical products is not as
explicit as the industrial commodities. First, pharmaceutical products involve a range of diverse
categories. One hospital purchaser mentioned:
The purchase specification for drug is messily complex. In many cases, we use
“box” as a purchase unit to procure syringe, in which we can never be sure how
many syringes one box may contain. Sometimes a box consists of ten syringes,
but other times there are twelve… And syringes are different in terms of lengths
and diameters. These specifications are unstructured and change frequently. The
e-sourcing system is less useful in this regard.
Second, the curative effect of pharmaceuticals is difficult to quantify and judge. Pharmaceutical
purchasing is heavily related to a doctor’s assessment of a patient’s illness. Many drug products
contain such tacit knowledge. As a result, the purchase requirement (RFP: Request for Proposal)
of these drugs and related items could not be easily articulated and negotiated. One medical
doctor noted:
Suppose you’ve got a cold. Some drugs can cure you in two days, while others
may take weeks… Well, the latter drugs are cheaper, but you will recover later.
And the later you’re recovered, the later you can work and thus your income
may suffer. Consider the loss. What’s more, for children, you need to take more
drugs to get recovered. But taking more drugs is definitely a bad thing for
children. In some cases, if the cold is not cured in time, it may harm your
respiratory tract. How can you calculate this cost?
The purchase of scalpel (for surgery) is another illustrative example. Scalpels are expensive
items and are purchased (through leasing model) on a just-in-time basis. An inaccurate order of
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scalpels may result in surgical difficulties (e.g. if the scalpel is too thin, it cannot cut through a
patient’s belly which is too fat). The sales representative has to personally visit the hospital and
understand the situation to suggest a proper choice of scalpels. At times, the sales representative
even has to stand beside the operating theater to facilitate the operation. (Note: these sales
representatives are experienced medical doctors before leaving their medical profession.) One
doctor recalled:
The sales who helps me with the scalpel was a surgeon…When we asked him to
demonstrate the products, he took out one scalpel and began to explain to us
how to use it—how to hold the scalpel, how to make a cut, which is explained in
exhaustive detail, like a medial professor. We have to rely on this knowledge to
purchase the correct scalpel because mostly our purchase depends on the
patient’s medical condition.
This explains why many doctors cast doubt on the fairness and reliability of centralized
e-sourcing. Pharmaceutical purchase needs to involve different fields of expertise. It is not
feasible to include experts from different medial profession in the appraisal committee. As a
result, this makes the definition of sourcing requirement extremely difficult for the committee
and frequently results in purchasing the wrong items at a higher price through e-sourcing. One
hospital purchaser observed:
The appraisal committee makes many purchase decision based on subjective
impression rather than objective measures. They choose a drug because it has
better “supplier reputation” – because one brand is more well-received than the
others. The decision is not based on how effective the drug is. The appraisal
committee also doesn’t have time to conduct on-site qualification. They rely
singly on publicized reports. Needless to say, these reports are severely biased in
China.
Misalignment in the organizational context: In this section, we analyze the organizational
context by investigating the hospital’s relationship with its suppliers (i.e. pharmaceutical
companies). Organizational context refers to whether the organizational culture is “generally
supportive of learning, change, and innovation” and the “compatibility between the values
implied by the practice and the values underlying the organizational culture” (Kostova 1999:
317).
For e-sourcing practice, an important value proposition is the cost savings resulting from
free-market competition. However, it is not the value that most Chinese hospitals behold, as one
pharmaceutical marketer mentioned:
In fact, it’s very difficult for a pharmaceutical manufacturer or supplier to
promote its products. If your product is not listed in the categories which can be
covered by the social security fund, you should quickly undertake some political
lobby actions. You must go through the Price Administration, Pharmacy
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Association, and Ministry of Health to promote your products. If you have no
political influence at all, you are already going out on a limb before joining the
e-bidding.
Therefore, most suppliers had more incentives to produce the approved categories of
pharmaceutical products than investing in R&D for new drugs. As a result, most pharmaceutical
manufacturers in China are relatively small and have little R&D competence. For the suppliers,
e-bidding is just a cosmetic work for justifying which drugs to be sold. The adoption of
e-sourcing is therefore ceremonial. One executive from a major pharmaceutical firm noted:
In China, real “new” pharmaceutical products are very few. Whenever a new
drug is developed, a lot of companies will start to copy it, all with different
quality. For example, you can see dozens of companies producing Cefradine (a
kind of broad-spectrum antibiotic) in China, including capsules, tablets,
granules…and each province or city normally will use its local brand. The local
government often excludes outsiders, in spite that their products may produce
better remedial effect. So you may find sometimes a particular type of drug
produced by this company disappears all in a sudden in the city. It is because the
government has closed the door for the outsider company.
Moreover, by colluding with hospitals, both sides can strive in the market economy system and
obtain higher profit margin. In these circumstances, neither hospitals nor suppliers have any
incentives to develop an organizational culture that is supportive of learning and change toward
the adoption of e-sourcing. One chief purchasing officer in a large hospital remarked:
In my view, e-sourcing is not a free market competition; it was manipulated by
suppliers. Bigger suppliers collude with smaller ones. Big and small suppliers
also collaborate with hospitals to influence the outcome of competitive bidding.
For example, you could change the packaging and double the price. A vaccine
supplier can produce 100 units per dose at the price of RMB 2.20. But they
increase the price to RMB 20.00 only by changing its vaccine to 200 units per
dose.
E-sourcing practices were also in conflict with the hospitals’ organizational culture. While
e-sourcing practices could bring in competition and transparency, hospitals were more worried
about the loss of incomes. A purchaser noted:
In Chinese healthcare sector, patients have little say in the drug price. The real
buyer are the medical doctors. Doctors can decide what to buy and how many to
buy. In China, doctors’ pay is miserable in comparison to the US. They also
need to sustain their families and make a living. If the hospital is not profitable,
everyone suffers. With the interest of patients in mind, the doctors will naturally
prefer to prescribe drugs that generate more profit. E-sourcing will throw the
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situation off balance.

5. Discussion and Conlusion
This paper analyzes the ineffective internalization of e-sourcing in the healthcare sector in China,
from a contextualist perspective. Although the implementation of e-sourcing was successful, the
internalization was regrettably ineffective. This failure must not be examined singly by market
control mechanism, unfavorable adoption conditions, and organization inertia. More importantly,
we also need analyze the misalignment stemmed from the societal, industrial and organizational
context, as summarized in Table 1. As suggested by the findings, at the societal level, the “free
market” assumption embedded in e-sourcing is misaligned with the regulated institutional
environment in China; at the industrial level, the unambiguous product specification required by
e-sourcing is misaligned with the pharmaceutical products imbued with tacit medical knowledge
that characterizes the healthcare industry; at the organizational level, the prerequisite
transparency demanded by e-sourcing is misaligned with the surviving strategy undertaken by
hospitals and suppliers.
With a deeper understanding of context, we understand that e-sourcing is appropriated to fit in a
regulated market. Although the outcome may not be favorable in terms of cost saving and
efficiency gain, the new way of using e-sourcing nevertheless help hospitals and pharmaceutical
companies survive in a market-oriented economy. From the contextulist analysis, we may
observe an interesting ecological system within the Chinese healthcare sector. The patients pay a
higher price for the medicine. This creates profits for hospitals and pharmaceutical companies.
The patients can claim these expenses from the social security systems. However, this will
increase the government’s financial burden. Thus, the local government replenishes its reserves
by taxing the pharmaceutical companies. The pharmaceutical companies the charge higher prices
to regain profit. At the end, it is an equilibrium system. However, this is only our initial
observation. More research works are required to understand better the economic impact of this
situation.
Table 1. Misalignment of e-sourcing in three contexts
Context assumed by e-sourcing
Societal context

•

Embedded in e-sourcing is a
“free-market” assumption,
which presumes open market
participations, information
transparency, and rational
transaction.
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Chinese healthcare industry
•

Regulated environment: The price
structure of pharmaceutical
products is highly regulated.

•

Cognitive inertia: medical
expenses should be subsidized by
the government.

Context assumed by e-sourcing

Chinese healthcare industry

Industrial
context

•

Rational purchase decisions are
based on unambiguous product
specification.

•

Pharmaceutical products are
unstructured and contain rich tacit
knowledge.

Organizational
context

•

Greater economic value (cost
and efficiency) is sustained by
intensive market competition.
This requires ongoing product
innovation and streamlines
ineffective processes within
firms.

•

The hospital’s organizational
culture is not conducive to
introducing e-sourcing (which
may affect its survival).

•

The suppliers have more incentive
to engage in political lobby rather
than to bolster innovation,
learning, and change.

•

The buyers (hospitals) and
suppliers (pharmaceutical
companies) are encouraged by the
social structure to collude and
e-sourcing become an artifact to
legitimate such collusion.

This study offers two key implications for research. First, it enriches our knowledge and
understanding of technology internalization through analyzing three embedded levels of context.
As most studies are concerned with technology implementation issues (e.g. Avgerou, 2001;
Kambil and van Heck, 1998; Lee and Clark, 1997; Walsham and Barrett, 1999), this offers an
initial analysis on the issue of technology internalization. Managerial incentives and market
control mechanisms may enable successful implementation but may not be sufficient for
exploiting the true value of technology. Without understanding the internalization issue, firms
may adopt technology ceremonially. Eventually, technology use may merely become a
disillusion to the adopter (Fichman, 1999). Additionally, this study builds on Kostova’s (1999)
framework on transnational technology (knowledge) transfer. Although Kostova’s conceptual
framework provides deep insights into analyzing cross-context technology transfer, this
framework is not yet explored using qualitative methods to assess its applicability. This study
provides a seminal attempt to elaborate Kostova’s framework and suggests the importance of the
contextualist perspective in future research on technology adoption and implementation.
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